Skip to main content
. 2022 Jul 2;10(7):1067. doi: 10.3390/vaccines10071067

Table 6.

Association between BNT162b2 and mortality adverse events from large-scale controlled surveillance studies.

Hviid et al. [29] Whiteley et al. [44] Xu et al. [61] Husby et al. [28]
Mortality Non-sig. HR: 0.24 ‡ - -
Non-COVID-19 mortality - - RR: 0.41 ⸸ -
Cardiac arrest or death - - - HR: 0.51

Abbreviations/acronyms: EC: excess cases; HR: hazard ratio; RR: risk or relative ratio. Notes: (i) non-sig. means not statistically significant; (ii) if EC is not provided, it is not available; (iii) hyphen (-) denotes not available, that is, unexamined. ‡ The risk is limited to individuals under 70 years only. In those over 70 years, the HR is 0.19. ⸸ The risk is limited to the post-first dose only. In the post-second dose, the RR is 0.34.